Download PDF
Dtsch Med Wochenschr 2011; 136(22): 1172-1174
DOI: 10.1055/s-0031-1280533
Hämatologie und Onkologie| Commentary
Hämatologie
© Georg Thieme Verlag KG Stuttgart · New York

Immunthrombozytopenie

Immune thrombocytopeniaA. Matzdorff1
  • 1Onkologisches Zentrum Saarbrücken, Klinik für Hämatologie und Onkologie, Caritasklinik St. Theresia
Further Information

Publication History

Publication Date:
24 May 2011 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Immunthrombozytopenie - Thrombopoietin-Rezeptorantagonisten - Romiplostim - Rituximab - Splenektomie

Keywords

immune thrombocytopenia - thrombopoietin receptor agonists - romiplostim - rituximab - splenectomy

Literatur

  • 1 Emmons R BV, Reid D M, Cohen R L. et al . Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.  Blood. 1996;  87 4068-4071
    Google Scholar
  • 2 Godeau B, Porcher R, Fain O. et al . Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura – results of a prospective multicenter phase 2 study.  Blood. 2008;  112 999-1004
    Google Scholar
  • 3 Kuter D J. New thrombopoietic growth factors.  Blood. 2007;  109 4607-4616
    Google Scholar
  • 4 Kuter D J, Rummel M, Boccia R. et al . Romiplostim or standard of care in patients wtih immune thrombocytopenia.  N Engl J Med. 2010;  363 1889-1899
    Google Scholar
  • 5 Matzdorff A, Giagounidis A, Greinacher A. et al . Diagnostik und Therapie der Immunthrombozytopenie. Empfehlungen einer gemeinsamen Expertengruppe der DGHO, DGTI und GTH.  Onkologie. 2010;  33 (Suppl 3) 2-20
    Google Scholar
  • 6 Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther M. Clinical guideline update on „Immune Thrombocytopenia: an evidence based practice guideline developed by the American Society of Hematology”.  Blood. 2011;  e-pub ahead of print
    Google Scholar
  • 7 Provan D, Stasi R, Newland A C. et al . International consensus report on the investigation and management of primary immune thrombocytopenia.  Blood. 2010;  115 168-196
    Google Scholar
  • 8 Rodeghiero F, Stasi R, Gernsheimer T. et al . Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura (ITP) of adults and children: Report from an International Working Group.  Blood. 2009;  113 2386-2393
    Google Scholar
  • 9 Zaja F, Baccarani M, Mazza P. et al . Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.  Blood. 2010;  115 2755-2762
    Google Scholar

Prof. Dr. med. A. Matzdorff

Onkologisches Zentrum Saarbrücken
Klinik für Hämatologie und Onkologie
Caritasklinik St. Theresia

Rheinstr. 2

66113 Saarbrücken

Phone: 0681/406-1101

Fax: 0681/406-1103

Email: a.matzdorff@caritasklinik.de

      >